Anixa Biosciences
ANIX
ANIX
35 hedge funds and large institutions have $15.2M invested in Anixa Biosciences in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
21% less call options, than puts
Call options by funds: $251K | Put options by funds: $317K
Holders
35
Holding in Top 10
–
Calls
$251K
Puts
$317K
Top Buyers
| 1 | +$418K | |
| 2 | +$323K | |
| 3 | +$264K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$239K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$200K |
Top Sellers
| 1 | -$500K | |
| 2 | -$79.9K | |
| 3 | -$78K | |
| 4 |
Morgan Stanley
New York
|
-$64K |
| 5 |
BlackRock
New York
|
-$36.8K |